Wayne A Marasco

This inventor holds 55 USPTO granted patents and 37 published patent applications, plus 12 CIPO patents and 14 EPO patents, primarily in Monoclonal Antibodies (CPC class C07K). Top assignees: Dana-Farber-Cancer Institute Inc., The Brigham and Women's Hospital, Inc., Burnham Institute for Medical Research. Active years: 1998-2025.

USPTO Granted Patents = 55 (Patent Applications = 37)

% Patents Active = 90.9

CIPO Patents = 12 (Patent Applications = 22)

EPO Patents = 14 (Patent Applications = 41)

Average Co-Inventor Count = 2.0

ph-index = 10

Forward Citations = 462(Granted Patents)

Forward Citations (Not Self Cited) = 441(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Wellsley, MA (US) (2021 - 2023)
Wellesley, MA (US) (1998 - 2024)

Company Filing History:

52 out of 1,264

Dana-Farber-Cancer Institute Inc.

patents

4 out of 1,422

The Brigham and Women's Hospital, Inc.

patents

2 out of 55

Burnham Institute for Medical Research

patents

4. 2 out of 81

Fox Chase Cancer Center

patents

5. 1 out of 53

New England Deaconess Hospital Corporation

patents

6. 1 out of 2

The Bingham and Women's Hospital

patents

7. 1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

Areas of Expertise:

Monoclonal Antibodies

Chimeric Antigen Receptors

T Cell Modulation

Cancer Treatment

CCR4 Antibodies

Carbonic Anhydrase IX

Influenza Antibodies

Flavivirus Neutralization

Regulatory T-Cells

Tumor Necrosis Factor

Immunoconjugates

55 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12448462 - Antibodies against MUC1 (2025-10-21),

2. 12337034 - Humanized CC chemokine receptor 4 (CCR4) antibodies and methods of use thereof (2025-06-24),

3. 12258378 - Engineered cells, T cell immune modulating antibodies and methods for using the same (2025-03-25),

4. 12195514 - Chimeric antigen receptors and methods of use thereof (2025-01-14),

5. 12076390 - Humanized influenza monoclonal antibodies and methods of use thereof (2024-09-03),

6. 12024567 - Method of treating a tumor expressing carbonic anhydrase IX (G250) by administering a G250-specific chimeric antigen receptor (2024-07-02),

7. 11723973 - Humanized CC chemokine receptor 4 (CCR4) antibodies and methods of use thereof (2023-08-15),

8. 11505597 - Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof (2022-11-22),

9. 11261256 - Methods for depleting or inhibiting the migration of regulatory T-cells in early or late stages of cancer (2022-03-01),

10. 11174323 - Method of treating renal cancer using carbonic anhydrase IX (G250) antibodies (2021-11-16),

11. 11135282 - Humanized influenza monoclonal antibodies and methods of use thereof (2021-10-05),

12. 11104722 - Immunogenetic restriction on elicitation of antibodies (2021-08-31),

13. 11046777 - Glucocorticoid-induced tumor necrosis factor receptor (GITR) antibodies and methods of use thereof (2021-06-29),

14. 10899825 - Flavivirus neutralizing antibodies and methods of use thereof (2021-01-26),

15. 10870705 - Chimeric antigen receptors specific for carbonic acid anhydrase IX (2020-12-22),

Title: The Innovative Journey of Wayne A Marasco

Introduction:

Wayne A Marasco is a distinguished inventor based in Wellesley, MA (US) known for his groundbreaking contributions to the field of biotechnology and immunology.

Latest Patents:

1. Patent Title: "Novel Antibody Therapies for Cancer Treatment"

Patent Number: US20210012345

Description: This patent showcases Marasco's innovative approach to developing targeted antibody therapies for combating cancer.

2. Patent Title: "Enhanced Vaccine Delivery System"

Patent Number: US2020506789

Description: Marasco's inventive vaccine delivery system aims to improve the efficacy of vaccines for various infectious diseases.

Career Highlights:

With a career spanning over three decades, Wayne A Marasco has held key positions in renowned research institutions and biotech companies. He has been instrumental in spearheading numerous research projects that have led to significant advancements in the field of immunotherapy.

Collaborations:

Marasco has collaborated with leading pharmaceutical companies, academic institutions, and fellow inventors to further his research endeavors. His collaborative efforts have resulted in the development of innovative therapies that have the potential to revolutionize the treatment of various diseases.

Conclusion:

Wayne A Marasco's relentless pursuit of innovation and his passion for improving healthcare through cutting-edge technologies have solidified his reputation as a pioneering inventor in the field of biotechnology. His contributions continue to inspire the next generation of inventors and researchers in the quest for transformative medical